Last reviewed · How we verify
Transforaminal Epidural Steroid Injections
At a glance
| Generic name | Transforaminal Epidural Steroid Injections |
|---|---|
| Also known as | Lumbar transforaminal epidural steroid Injection was administered, consisting of 4 mg dexamethasone and 0.33% lidocaine in a 3 ml solution |
| Sponsor | Muhammad Aamir Latif |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Inflammatory Markers in Lumbar Radicular Pain Treated With PRF and TFESI
- Patient Satisfaction During Lomber Transforaminal Epidural Steroid Injection: The Role of Sedation, Anxiety, and Pain
- "Effectiveness of Physical Therapy Added to Transforaminal Injection in Lumbar Radicular Pain"
- PLDD With or Without Transforaminal Epidural Steroid Injection in Lumbar Disc Herniation
- The Effect of Adding a Local Anesthetic to Transforaminal Epidural Injection in Cervical Disc Herniation. (NA)
- The Role of Temporal Changes in Pain Response After Transforaminal Epidural Steroid Injection on Treatment Success
- Impact of Sedation on Patient Satisfaction, Radiation Exposure, and Complications in Lumbar Transforaminal Epidural Steroid Injections: A Retrospective Cohort Study
- Transforaminal Versus Lateralized Interlaminar Cervical Epidurals (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: